Search

everythinglearnresearchcommunity

for

Search:↓

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Antiandrogen therapy, like cyproterone acetate, effectively treats acne, hirsutism, and hair loss.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

New progesterone-based compounds can block male hormones.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Androgens can cause acne, excess hair, and hair loss, treatable with dermatologist-guided therapies.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

New steroids were effective in blocking male hormone receptors in hamster prostates.

New compounds may help treat prostate issues without affecting androgen receptors.

Anti-androgens can help reduce the effects of male hormones on the skin.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Topical antiandrogens might treat skin issues like hair growth, balding, and acne, but finding effective treatments without side effects is challenging.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Androgens affect skin conditions like acne and hair loss through specific biochemical pathways.

Beard hair follicles convert testosterone to 5α-dihydrotestosterone most intensively.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.